The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis

QR Code

The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis

Purpose of Review: Atherosclerosis is an inflammatory disorder of the arterial wall, in which several players contribute to the onset and progression of the disease. Besides the well-established role of lipids, specifically cholesterol, and immune cell activation, new insights on the molecular mecha...

Full description

Bibliographic Details
Main Authors:	Pirillo, A., Bonacina, F., Norata, Giuseppe, Catapano, A.
Format:	Journal Article
Published:	Springer Healthcare 2018
Online Access:	http://hdl.handle.net/20.500.11937/67764

Similar Items

HDLs, immunity, and atherosclerosis
by: Norata, Giuseppe, et al.
Published: (2011)

High density lipoproteins and atherosclerosis: Emerging aspects
by: Sala, F., et al.
Published: (2012)

Emerging role of high density lipoproteins as a player in the immune system
by: Norata, Giuseppe, et al.
Published: (2012)

MicroRNAs and lipoproteins: A connection beyond atherosclerosis?
by: Norata, Giuseppe, et al.
Published: (2013)

HDL in innate and adaptive immunity
by: Catapano, A., et al.
Published: (2014)

LOX-1, OxLDL, and atherosclerosis
by: Pirillo, A., et al.
Published: (2013)

High-density lipoprotein subfractions - What the clinicians need to know
by: Pirillo, A., et al.
Published: (2013)

Treating high density lipoprotein cholesterol (HDL-C): Quantity versus quality
by: Pirillo, A., et al.
Published: (2013)

Vascular inflammation and low-density lipoproteins: Is cholesterol the link? A lesson from the clinical trials
by: Catapano, A., et al.
Published: (2017)

HDL and adaptive immunity: A tale of lipid rafts
by: Norata, Giuseppe, et al.
Published: (2012)

Biology of proprotein convertase subtilisin kexin 9: Beyond low-density lipoprotein cholesterol lowering
by: Norata, Giuseppe, et al.
Published: (2016)

Leonurine: A new comer in the natural compounds affecting atherosclerosis
by: Norata, Giuseppe, et al.
Published: (2012)

The CD1d-natural killer T cell axis in atherosclerosis
by: Bondarenko, S., et al.
Published: (2014)

Pentraxins and atherosclerosis
by: Barbati, E., et al.
Published: (2014)

Translating the biology of adipokines in atherosclerosis and cardiovascular diseases: Gaps and open questions
by: Ruscica, M., et al.
Published: (2017)

Postprandial lipemia as a cardiometabolic risk factor
by: Pirillo, A., et al.
Published: (2014)

Therapy and clinical trials: Aggressive statin therapy versus combined and emerging approaches
by: Catapano, A., et al.
Published: (2011)

Niemann-pick C1-like 1 (NPC1L1) inhibition and cardiovascular diseases
by: Pirillo, A., et al.
Published: (2016)

HDL in infectious diseases and sepsis
by: Pirillo, A., et al.
Published: (2015)

Targeting Cholesterol in Non-ischemic Heart Failure: A Role for LDLR Gene Therapy?
by: Catapano, A., et al.
Published: (2017)

Strategies for the use of nonstatin therapies
by: Pirillo, A., et al.
Published: (2017)

Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: Patient selection and perspectives
by: Catapano, A., et al.
Published: (2017)

Long pentraxin 3: Experimental and clinical relevance in cardiovascular diseases
by: Bonacina, F., et al.
Published: (2013)

Effect of Tie-2 conditional deletion of BDNF on atherosclerosis in the ApoE null mutant mouse
by: Norata, Giuseppe, et al.
Published: (2012)

Effector memory T cells are associated with atherosclerosis in humans and animal models
by: Ammirati, E., et al.
Published: (2012)

Apolipoprotein C-III: From Pathophysiology to Pharmacology
by: Norata, Giuseppe, et al.
Published: (2015)

Notch Signaling Regulates Immune Responses in Atherosclerosis
by: Vieceli Dalla Sega, F., et al.
Published: (2019)

IDOL N342S variant, atherosclerosis progression and cardiovascular disorders in the italian general population
by: Dhyani, A., et al.
Published: (2015)

Subclinical atherosclerosis is associated with Epicardial Fat Thickness and hepatic steatosis in the general population
by: Baragetti, A., et al.
Published: (2016)

HDL: To treat or not to treat?
by: Pirillo, A., et al.
Published: (2014)

PCSK9 inhibition in statin-intolerant HeFH patients: What's new?
by: Casula, M., et al.
Published: (2017)

High density lipoprotein cholesterol levels are an independent predictor of the progression of chronic kidney disease
by: Baragetti, A., et al.
Published: (2013)

Proprotein Convertase Subtilisin-Kexin type-9 (PCSK9) and triglyceride-rich lipoprotein metabolism: Facts and gaps
by: Baragetti, A., et al.
Published: (2018)

Genetically determined telomeres shortening is associated with carotid atherosclerosis progression and increased incidence of cardiovascular events
by: Baragetti, A., et al.
Published: (2016)

The missing link between high-density lipoprotein cholesterol and inflammatory response in cardiovascular disease
by: Ammirati, E., et al.
Published: (2014)

Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: The atherosclerosis risk in communities study
by: Lopez, F., et al.
Published: (2012)

MiR-143/145 deficiency attenuates the progression of atherosclerosis in Ldlr-/- mice
by: Sala, F., et al.
Published: (2014)

Trained immunity and cardiovascular disease: Is it time for translation to humans?
by: Norata, Giuseppe
Published: (2018)

Signalling pathways regulating galactosaminoglycan synthesis and structure in vascular smooth muscle: implications for lipoprotein binding and atherosclerosis
by: Afroz, Rizwana, et al.
Published: (2018)

Markers of inflammation associated with plaque progression and instability in patients with carotid atherosclerosis
by: Ammirati, E., et al.
Published: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qn0ec52lc67ve8kki88ef7rmga